Histological and immunohistochemical characteristics of ACTH-secreting tumors

Lapshina A.M.; Voronkova I.A.; Marova E.I.

doi:https://doi.org/

Lapshina A.M.

FGU Éndokrinologicheskiĭ nauchnyĭ tsentr, Moskva

Voronkova I.A.

FGU Éndokrinologicheskiĭ nauchnyĭ tsentr, Moskva

Marova E.I.

Endocrinology Research Centrer

Histological and immunohistochemical characteristics of ACTH-secreting tumors

Authors:

Lapshina A.M., Voronkova I.A., Marova E.I.

More about the authors

Journal: Russian Journal of Archive of Pathology. 2013;75(3): 8‑13

Read: 2046 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Lapshina AM, Voronkova IA, Marova EI. Histological and immunohistochemical characteristics of ACTH-secreting tumors. Russian Journal of Archive of Pathology. 2013;75(3):8‑13. (In Russ.)

Подписка 2026 Архив патологии (Russian Journal of Archive of Pathology)

Использование инфографики авторами научных работ

Close metadata

Abstract:

The histological and immunohistochemical characteristics of pituitary (corticotropinomas) and nonpituitary adrenocorticotropic hormone (ACTH)-secreting neuroendocrine tumors (NET) were comparatively analyzed. The study included 46 corticotropinomas and 37 ectopic ACTH-secreting tumors. Removed NET tissue was investigated using routine histological and immunohistochemical techniques. A study of the morphofunctional characteristics of removed NETs yielded the following data: their ability to express ACTH, growth hormone, luteinizing hormone, follicle-stimulating hormone, and prolactin in both in pituitary and nonpituitary NET tumors. Angiogenic markers (CD31 and VEGF) were found in equal frequency. The histological structure of all corticotropinomas suggested their benign origin while nonpituitary NETs had different morphological structures, malignancy and invasiveness grades, and metastatic properties. The highest cell proliferation potential (Ki-67) was discovered in NET in ectopic ACTH syndrome as compared to corticotropinomas.

Keywords:

ACTH-secreting tumors

histological and immunohistochemical study

expression of pituitary hormones

Ki-67

CD31

and VEGF

Authors:

Lapshina A.M.

FGU Éndokrinologicheskiĭ nauchnyĭ tsentr, Moskva

Voronkova I.A.

FGU Éndokrinologicheskiĭ nauchnyĭ tsentr, Moskva

Marova E.I.

Endocrinology Research Centrer

Close metadata

References:

Arapova S.D. AKTG-ektopicheskii sindrom. V kn.: Dedov I.I., red. Klinicheskaya neiroendokrinologiya. M.: UP Print; 2011: 97-8.
LiVolsi V.A., Asa S.L. Endocrine pathology. Churchill Livingstone; 2002: 46-8.
Asthagiri A., Lopes M. Neuropathological considerations of pituitary adenomas. In: Laws E.R. Sheehan J.P., eds. Pituitary surgery - a modern approach. Basel: Karger; 2006: 206-27.
Gregory A.K., Besser G.M., Grossman A.B. The diagnosis and medical management of advanced neuroendocrine tumors. Endocr. Rev. 2004; 25 (3): 458-511.
Gurevich L.E. Diagnostika neiroendokrinnykh opukholei zheludochno-kishechnogo trakta. Prakticheskaya onkologiya. 2005; 6 (4): 193-4.
Frank G.A. Osnovnye klassifikatsii neiroendokrinnykh opukholei legkikh. V kn.: Neiroendokrinnye opukholi legkikh. M.: Prakticheskaya meditsina; 2012: 36-46.
Salgado L.R., Fragoso M.K., Knoepfelmacher M. et al. Ectopic ACTH syndrome: our experience with 25 cases. Eur. J. Endocrinol. 2006; 155: 725-33.
Reuss W.A., Saeger W., Lüdecke D.K. Electron microscopical morphometry of well-differentiated and undifferentiated ACTH secreting adenomas in Cushing's disease and Nelson's syndrome. Virchows Archiv A. Pathol. Anat. Histopathol. 1991; 419 (5): 395-401.
Weidner N. Measuring intratumoral microvessel density. Methods Enzymol. 2008; 444 (1): 305-23.
Turner H.E., Nagy Z.S., Gatter K.C. et al. Angiogenesis in pituitary adenomas - relationship to endocrine function, treatment and outcome. J. Endocrinol. 2000; 165: 475-81.
Mubarak Al-G., Horvath E., Kalman K. Pituitary hyperplasia. Hormones. 2003; 2 (3): 149-58.
Zemskova M.S., Gundabolu B., Sinaii N. et al. Utility of various functional and anatomic imaging modalities for detection of ectopic adrenocorticotropin-secreting tumors. J. Clin. Endocrinol. Metab. 2010; 95 (3): 1207-19.
Grimaldi F., Muser D., Beltrami C.A. et al. Partitioning of bronchopulmonary carcinoids in two different prognostic categories by Ki-67 score. Front. Endocrinol. (Lausanne). 2011; 2: 20.
Turner H.E., Harris A.L., Melmed Sh. et al. Angiogenesis in endocrine tumors. Endocr. Rev. 2003; 24 (5): 600-32.
Zhang J., Jia Z., Li Q. et al. Elevated expression of vascular endothelial growth factor correlates with increased angiogenesis and decreased progression-free survival among patients with low-grade neuroendocrine tumors. Cancer. 2007; 109: 1478-86.